Effect of Empagliflozin on Left Ventricular Volumes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF) (Q102056712)
Jump to navigation
Jump to search
scientific article published on 13 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of Empagliflozin on Left Ventricular Volumes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF) |
scientific article published on 13 November 2020 |
Statements
Effect of Empagliflozin on Left Ventricular Volumes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF) (English)
1 reference
Matthew M Y Lee
Katriona J M Brooksbank
Kirsty Wetherall
Kenneth Mangion
Giles Roditi
Ross T Campbell
Colin Berry
Victor Chong
Liz Coyle
Kieran F Docherty
John G Dreisbach
Catherine Labinjoh
Ninian N Lang
Vera Lennie
Alex McConnachie
Clare L Murphy
Colin J Petrie
John R Petrie
Iain A Speirits
Steven Sourbron
Paul Welsh
Rosemary Woodward
Aleksandra Radjenovic
John J V McMurray
Pardeep S Jhund
Mark C Petrie
Naveed Sattar
13 November 2020